Medri L - Search Results

1

NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.

Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W. Tesei A, et al. Among authors: medri l. Int J Oncol. 2003 Jun;22(6):1297-302. Int J Oncol. 2003. PMID: 12738997

2

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.

Tesei A, Rosetti M, Ulivi P, Fabbri F, Medri L, Vannini I, Bolla M, Amadori D, Zoli W. Tesei A, et al. Among authors: medri l. J Transl Med. 2007 Oct 30;5:52. doi: 10.1186/1479-5876-5-52. J Transl Med. 2007. PMID: 17971198 Free PMC article.

3

c-kit and SCF expression in normal and tumor breast tissue.

Ulivi P, Zoli W, Medri L, Amadori D, Saragoni L, Barbanti F, Calistri D, Silvestrini R. Ulivi P, et al. Among authors: medri l. Breast Cancer Res Treat. 2004 Jan;83(1):33-42. doi: 10.1023/B:BREA.0000010694.35023.9e. Breast Cancer Res Treat. 2004. PMID: 14997053

4

Usefulness of immunological detection of the human telomerase reverse transcriptase.

Volpi A, Bravaccini S, Medri L, Cerasoli S, Gaudio M, Amadori D. Volpi A, et al. Among authors: medri l. Cell Oncol. 2005;27(5-6):347-53. doi: 10.1155/2005/808343. Cell Oncol. 2005. PMID: 16373967 Free PMC article.

5

Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts.

Leonetti C, Scarsella M, Zupi G, Zoli W, Amadori D, Medri L, Fabbri F, Rosetti M, Ulivi P, Cecconetto L, Bolla M, Tesei A. Leonetti C, et al. Among authors: medri l. Mol Cancer Ther. 2006 Apr;5(4):919-26. doi: 10.1158/1535-7163.MCT-05-0536. Mol Cancer Ther. 2006. PMID: 16648562

6

In vitro irradiation system for radiobiological experiments.

Tesei A, Sarnelli A, Arienti C, Menghi E, Medri L, Gabucci E, Pignatta S, Falconi M, Silvestrini R, Zoli W, D'Errico V, Romeo A, Parisi E, Polico R. Tesei A, et al. Among authors: medri l. Radiat Oncol. 2013 Nov 1;8:257. doi: 10.1186/1748-717X-8-257. Radiat Oncol. 2013. PMID: 24180359 Free PMC article.

7

Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.

Arienti C, Zoli W, Pignatta S, Carloni S, Paganelli G, Ulivi P, Romeo A, Menghi E, Sarnelli A, Medri L, Polico R, Silvestrini R, Tesei A. Arienti C, et al. Among authors: medri l. J Cell Physiol. 2014 Oct;229(10):1548-56. doi: 10.1002/jcp.24598. J Cell Physiol. 2014. PMID: 24591063

8

Vascular endothelial growth factor and prognosis in patients with node-negative breast cancer.

De Paola F, Granato AM, Scarpi E, Monti F, Medri L, Bianchi S, Amadori D, Volpi A. De Paola F, et al. Among authors: medri l. Int J Cancer. 2002 Mar 10;98(2):228-33. doi: 10.1002/ijc.10118. Int J Cancer. 2002. PMID: 11857413 Free article.

9

Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact.

Ibrahim T, Farolfi A, Scarpi E, Mercatali L, Medri L, Ricci M, Nanni O, Serra L, Amadori D. Ibrahim T, et al. Among authors: medri l. Oncology. 2013;84(3):150-7. doi: 10.1159/000345795. Epub 2012 Dec 19. Oncology. 2013. PMID: 23257904

10

Biofunctional characteristics of in situ and invasive breast carcinoma.

Bravaccini S, Granato AM, Medri L, Foca F, Falcini F, Zoli W, Ricci M, Lanzanova G, Masalu N, Serra L, Buggi F, Folli S, Silvestrini R, Amadori D. Bravaccini S, et al. Among authors: medri l. Cell Oncol (Dordr). 2013 Jul;36(4):303-10. doi: 10.1007/s13402-013-0135-7. Epub 2013 Jun 27. Cell Oncol (Dordr). 2013. PMID: 23807750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page